Neogen Corporation Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Neogen Corporation (NEOG) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $0 for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-07-30
- Neogen Corporation noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-05-31 was $0.00.
- Neogen Corporation noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-05-31 was $0.00.
- Neogen Corporation noncash or part noncash acquisition, fixed assets acquired for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- Neogen Corporation noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $900.00K.
- Neogen Corporation noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $0.00.
- Neogen Corporation noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month as first filed | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $0.00 10-K · filed 2026-07-30 | |||
| 2026-02-28 | $0.00 10-Q · filed 2026-04-09 | ||||
| 2025-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $900.00K 10-K · filed 2026-07-30 | $930.00K 10-K · filed 2025-07-30 | ||
| 2025-02-28 | $900.00K 10-Q · filed 2026-04-09 | $930.00K 10-Q · filed 2025-04-09 | |||
| 2024-05-31 | $0.00 10-K · filed 2026-07-30 | ||||
| 2023-05-31 | $0.00 10-K · filed 2025-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |